YH, J., YJ, L., T, D., KH, J., J, Y., AR, O., . . . K, K. (2024). KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression. Clinical and molecular hepatology, 30(4), 895. https://doi.org/10.3350/cmh.2024.0364
Chicago Style (17th ed.) CitationYH, Jung, et al. "KCTD17-mediated Ras Stabilization Promotes Hepatocellular Carcinoma Progression." Clinical and Molecular Hepatology 30, no. 4 (2024): 895. https://doi.org/10.3350/cmh.2024.0364.
MLA (9th ed.) CitationYH, Jung, et al. "KCTD17-mediated Ras Stabilization Promotes Hepatocellular Carcinoma Progression." Clinical and Molecular Hepatology, vol. 30, no. 4, 2024, p. 895, https://doi.org/10.3350/cmh.2024.0364.
Warning: These citations may not always be 100% accurate.